Home > Monogram Biosciences Salary

Monogram Biosciences Salary

  • 98
  • 39
  • 24
Monogram Biosciences average salary is $65,435, median salary is $65,435 with a salary range from $65,435 to $65,435.
Monogram Biosciences salaries are collected from government agencies and companies. Each salary is associated with a real job position. Monogram Biosciences salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 1 Monogram Biosciences Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Software Engineer 65,435-65,435 Tucson, AZ, 85701 2010 Monogram Biosciences Software Engineer Salaries (1)
Monogram Biosciences Tucson, AZ Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Monogram Biosciences salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Monogram Biosciences Jobs
Specialty Development Executive - 77040
Laboratory Corporation of America - Houston, TX
See more Monogram Biosciences Jobs»
Search All Jobs

JobsOpenHiring – Find open jobs faster
Monogram Biosciences... Information
  • Monogram Biosciences Inc.
  • Industry: BioTech/Drugs
  • City: South San Francisco, CA
  • ViroLogic is a biotechnology company advancing individualized medicine and pharmacogenomics by discovering, developing and marketing innovative products to guide and improve treatment of serious viral diseases such as AIDS and hepatitis. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines targeted at emerging drug-resistant viruses.